• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

CATEGORIES

  • 6
  • 5
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

2
2
16
20

PUBLISHED

0
1
6
20

PRODUCT TYPE

18
2

Search "Theravance Inc.-Therapeutic Competitors" returned 20 results.

Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth

The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from $16 6 billion in 2012 to a projected value of $21 6 billion in 2019 This growth...

October 2013
FROM

Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth

The global COPD market is estimated to currently be worth $11 3 billion, and is forecast to reach a value of $15 6 billion by 2019 Much of this growth will be fuelled by a high number of new, more efficacious...

June 2013
FROM

Gastric Motility Disorder - Pipeline Review, H1 2014

Gastric Motility Disorder - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Gastric Motility Disorder - Pipeline Review, H1 2014’, provides an overview of the Gastric Motility Disorder’s...

April 2014
FROM

Fibromyalgia - Pipeline Review, H1 2014

Fibromyalgia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Fibromyalgia - Pipeline Review, H1 2014’, provides an overview of the Fibromyalgia’s therapeutic pipeline. This report provides...

April 2014
FROM

Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2014

Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2014’, provides an overview of the Opioid-Induced...

February 2014
FROM

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2014

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2014’, provides an...

March 2014
FROM

Gastroparesis - Pipeline Review, H1 2015

Gastroparesis - Pipeline Review, H1 2015 Summary This, ‘Gastroparesis - Pipeline Review, H1 2015’, provides an overview of the Gastroparesis’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2014

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2014’, provides an overview of the Hospital Acquired...

June 2014
FROM

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H1 2014

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline...

March 2014
FROM

Fibromyalgia - Pipeline Review, H2 2014

Fibromyalgia - Pipeline Review, H2 2014 Summary This, ‘Fibromyalgia - Pipeline Review, H2 2014’, provides an overview of the Fibromyalgia’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Gastroparesis - Pipeline Review, H2 2014

Gastroparesis - Pipeline Review, H2 2014 Summary This, ‘Gastroparesis - Pipeline Review, H2 2014’, provides an overview of the Gastroparesis’s therapeutic pipeline. This report provides comprehensive...

December 2014
FROM

Community-Acquired Bacterial Pneumonia - Pipeline Review, H1 2014

Community-Acquired Bacterial Pneumonia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Community-Acquired Bacterial Pneumonia - Pipeline Review, H1 2014’, provides an overview of the...

May 2014
FROM

Alzheimer's Disease - Pipeline Review, H1 2014

Alzheimer's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2014’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This...

February 2014
FROM

Hepatitis C - Pipeline Review, H1 2014

Hepatitis C - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H1 2014’, provides an overview of the Hepatitis C’s therapeutic pipeline. This report provides...

February 2014
FROM

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2014

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2014’, provides an overview of the Ventilator...

February 2014
FROM

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2014

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2014 Summary This, ‘Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2014’, provides an overview of the Ventilator Associated...

July 2014
FROM

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2014

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2014’, provides an overview...

February 2014
FROM

Ironwood Pharmaceuticals, Inc. (IRWD) - Financial and Strategic SWOT Analysis Review

Ironwood Pharmaceuticals, Inc. (IRWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been...

May 2015
FROM

Cubist Pharmaceuticals, Inc. (CBST) - Financial and Strategic SWOT Analysis Review

Cubist Pharmaceuticals, Inc. (CBST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2014
FROM

Fibromyalgia - Pipeline Review, H1 2015

Fibromyalgia - Pipeline Review, H1 2015 Summary This, ‘Fibromyalgia - Pipeline Review, H1 2015’, provides an overview of the Fibromyalgia’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM
Loading Indicator

Our Clients

Glanbia Plc. Unilever N.V. Microsoft Corporation Duke University A.T. Kearney PepsiCo Inc. Boston Consulting Group